Poster Session 1: Supportive Care

Track: Poster Abstracts
Wednesday, February 26, 2014: 6:45 PM-7:45 PM
Longhorn Hall E (Exhibit Level 1) (Gaylord Texan)

278
Role of Early Initiation of Continuous Veno-Venous Hemofiltration (CVVH) for Management of Sinusoidal Obstructive Syndrome (SOS) Following Stem Cell Transplant (SCT)
Rupesh Raina, MD, Rainbow Babies and Children's Hospital at Case Western Reserve University School of Medicine; Beth Vogt, MD, Rainbow Babies and Children's Hospital at Case Western Reserve University School of Medicine; Robert Cunningham, MD, Rainbow Babies and Children's Hospital at Case Western Reserve University School of Medicine; Linda Cabral, P.A., Rainbow Babies and Children's Hospital at Case Western Reserve University School of Medicine; Ghada Abusin, MD, University of Iowa Hospitals and Clinics; Jeffery J. Auletta, MD, Nationwide Children's Hospital; Kenneth R. Cooke, MD, Johns Hopkins University; Rolla Abu-Arja, MD, Rainbow Babies and Children's Hospital at Case Western Reserve University School of Medicine

279
Transplant- Associated Thrombotic Microangiopathy in a Beta-Thalassemia Major Patient Following Bone Marrow Transplant- Case Report
Ghada Abusin, MD, University of Iowa Hospitals and Clinics; Ugochi Ogu, MD, University of Iowa; Ayman Aly El-Sheikh, MD, University of Iowa Hosp & Clinics; Steve Rumelhart, PA-C, University of Iowa Children's Hospital; Diana Zepeda-Orozco, MD, University of Iowa; Rolla Abu-Arja, MD, Rainbow Babies and Children's Hospital at Case Western Reserve University School of Medicine; Carla Nester, MD, University of Iowa

280
Continuous Intravenous Immunoglobulin and Platelet Infusion in Allogeneic Stem Cell Transplant Patients with Allo-Immune Thrombocytopenia
Katerina Ancevski, MD, University of Wisconsin Hospital and Clinics; Rachel Cook, MD, University of Wisconsin, School of Medicine; Sara Koth, University of Wisconsin Hospital and Clinics; Mike Fallon, PharmD, University of Wisconsin Hospital and Clinics

281
Neck Tenderness As an Initial Presentation of Disseminated Aspergillosis; FNA Is an Option or a Must?
Sherif Badawy, M.D., Lurie Children's Hospital of Chicago - Northwestern University; Jennifer Schneiderman, M.D., Lurie Children's Hospital of Chicago - Northwestern University

282
Low Dose Defibrotide for Management of Hepatic Veno-Occlusive Disease
Bhausaheb Bagal, MD, DM., BMT Unit, ACTREC; Aliya Choughale, BSC, BMT Unit, ACTREC; Navin Navin Khattry, MD, DM., BMT Unit, ACTREC

283
Follow-up of Vaccination Status in Adults after Allogeneic Hematopoietic Stem Cell Transplantation
Tiene Bauters, Ghent University Hospital; Lise Dinh, Ghent University Hospital; Johan De Munter, Ghent University Hospital; Marijke Quaghebeur, Ghent University Hospital; Dominiek Mazure, Ghent University Hospital; Lucien Noens, Ghent University Hospital; Tessa Kerre, Ghent University Hospital

284
Tolerability of Foscarnet As a Continuous Infusion for Treatment of Herpesvirus Infections
Janice (Wes) M Brown, MD, Stanford Univ Med Ctr; Abraham Chang, Pharm D, Stanford Hospital and Clinics; Fu-ying Lee-Lam, Pharm D, Stanford Hospital and Clinics; Susanna K Tan, MD, Stanford University; Sumana Shashidhar, MS, MA, Stanford University

285
Successful Treatment of Post-Transplant Immune Thrombocytopenia with Romiplostim in a Pediatric Patient with X-Linked Chronic Granulomatous Disease
David Buchbinder, MD, Children's Hospital of Orange County; Loan Hsieh, MD, Children's Hospital of Orange County; Robert A. Krance, MD, Baylor College of Medicine, Texas Children's Hospital; Diane Jean Nugent, MD, Children's Hospital of Orange County

286
The Psychological State of Pediatric Patients before and after an HSCT
Mariana Campos, Instituto Nacional de Pediatría; Alberto Olaya, Instituto Nacional de Pediatría; Martin Pérez, Instituto Nacional de Pediatría; Sofia Campos, Instituto Nacional de Pediatría

288
Physical and Psychological Symptom Burden and Prognostic Understanding during Hospitalization for Hematopoietic Stem Cell Transplantation
Areej El-Jawahri, MD, Dana-Farber Cancer Institute; Lara Traeger, PhD, Massachusetts General Hospital; Kailyn Kuzmuk, Massachusetts General Hospital; Justin Eusebio, Massachusetts General Hospital; Emily Gallagher, Massachusetts General Hospital; Harry VanDusen, Massachusetts General Hospital; Joseph Greer, PhD, Massachusetts General Hospital; William Pirl, MD, Massachusetts General Hospital; Karen K. Ballen, MD, Massachusetts General Hospital; Thomas R. Spitzer, MD, Massachusetts General Hospital; Steven L. McAfee, MD, Massachusetts General Hospital; Bimalangshu R Dey, MD, PhD, Massachusetts General Hospital; Vicki Jackson, MD, Massachusetts General Hospital; Yi-Bin Chen, MD, Massachusetts General Hospital; Jennifer Temel, MD, Massachusetts General Hospital

289
Risk Factors for Infections in Recipients of Hematopoietic Cell Transplantation in Relation to Donor Source
Aron Flagg, MD, Cleveland Clinic; Rabi Hanna, MD, Cleveland Clinic; Sherif B Mossad, MD, Cleveland Clinic Foundation; Lisa Rybicki, MS, Cleveland Clinic Taussig Cancer Institute; Betty Ky Hamilton, MD, Cleveland Clinic Taussig Cancer Institute; Aaron Gerds, MD, MS, Cleveland Clinic Taussig Cancer Institute; Ronald Sobecks, MD, Taussig Cancer Institute, Cleveland Clinic; Hien Duong, MD, Cleveland Clinic Foundation; Steven Andresen, DO, Cleveland Clinic Taussig Cancer Institute; Brian Bolwell, MD, Cleveland Clinic Foundation; Navneet S. Majhail, MD, MS, Cleveland Clinic Foundation; Matt E. Kalaycio, MD, Cleveland Clinic Taussig Cancer Institute

290
Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Gunhan Gurman, MD, Ankara University Faculty of Medicine; Erden Atilla, Ankara University Faculty of Medicine; Mehmet Ozen, Ankara University Faculty of Medicine; Pinar Kubilay, Ankara University Faculty of Medicine; Gulden Yilmaz, Ankara University Faculty of Medicine; Mehmet Gunduz, Ankara University Faculty of Medicine; Onder Arslan, Ankara University Faculty of Medicine; Muhit Ozcan, MD, Ankara University School of Medicine; Taner Demirer, MD, Ankara University Faculty of Medicine; Hamdi Akan, MD, Ankara University Faculty of Medicine; Osman Ilhan, MD, Ankara University School of Medicine; Meral Beksac, MD, Ankara University School of Medicine; Pervin Topcuoglu, Ankara University Faculty of Medicine

291
Methodological Issues in Exercise Intervention Studies: Attrition and Adherence
Eileen Danaher Hacker, PhD, APN, AOCN, University of Illinois at Chicago; Maral Mjukian, BSN, RN, University of Illinois at Chicago

292
Differential Effect of Supersaturated Calcium Phosphate Rinse and Palifermin on Oral Mucositis Induced By Conditioning with Fludarabine, Busulfan and TBI or Melphalan
Tarik Hadid, M.D., M.S., Western Pennsylvania Cancer Institute; Entezam A Sahovic, M.D., Western Pennsylvania Cancer Institute; Gina Berteotti, Western Pennsylvania Cancer Institute; John Lister, M.D., Western Pennsylvania Cancer Institute

294
Significant Transplant-Related Mortality from Respiratory Virus Infections within the First 100 Days Post Hematopoietic Stem Cell Transplantation
Sakara Hutspardol, MD, Hospital for Sick Children; Tal Schechter-Finkelstein, MD, Hospital for Sick Children; Muhammad Ali, MD, The Hospital for Sick Children; Joerg Krueger, MD, The Hospital for Sick Children; R. Maarten Egeler, MD, PhD, Hospital for Sick Children; Upton Allen, MBBS, MSc, FAAP, FRCPC, Hospital for Sick Children; Susan Richardson, MD, FRCP(C), Hospital for Sick Children; Adam Gassas, MD, MBChB, MSc, MRCP, DCH, The Hospital for Sick Children

295
Risk Factors for Falls with Injury for Patients Admitted for Hematopoietic Stem Cell Transplant
Anne M McDonnell, PharmD, BCOP, Brigham and Women's Hospital; Shuli Li, Dana-Farber Cancer Institute; Kelly Connelly, PharmD, Smilow Cancer Hospital at Yale New-Haven; Brett Glotzbecker, MD, Dana-Farber Cancer Institute; Edwin P. Alyea III, MD, Dana-Farber Cancer Institute; Joseph H Antin, MD, Dana-Farber Cancer Institute; Robert J. Soiffer, MD, Dana-Farber Cancer Institute; Sylvia Bartel, Rph, MPH, Dana Farber Cancer Institute

296
Early Use of Inhaled Ribavirin Can Improve Outcomes in High Risk Hematopoietic Stem Cell Transplant and Leukemia Patients with RSV Infection
Ron Mihelic, PharmD, The Blood and Marrow Transplant Program at Northside Hospital; Lawrence Morris, MD, The Blood and Marrow Transplant Program at Northside Hospital; H. Kent Holland, MD, The Blood and Marrow Transplant Program at Northside Hospital; Asad Bashey, MD PhD, The Blood and Marrow Transplant Program at Northside Hospital; Xu Zhang, PhD, Ga State University Mathematics; Scott R. Solomon, MD, The Blood and Marrow Transplant Program at Northside Hospital

297
Physical Therapy during the Hemopoietic Stem Cell Transplant Process to Improve Quality of Life
Andrea Jana Gevedon, PT, DPT, Cincinnati Children's Hospital Medical Center; Mariann Strenk, PT, DPT, MHS, CCHMC; Jessica King Monfreda, PT, DPT, Cincinnati Children's Hospital Medical Center

298
Nephrotoxicity of Co-Administration of Tacrolimus and Teicoplanin in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Takehiko Mori, Keio University School of Medicine; Takayuki Shimizu, Keio University School of Medicine; Jun Kato, MD, Keio University School of Medicine; Sumiko Kohashi, MD, Keio University School of Medicine; Yuya Koda, Keio University School of Medicine; Masuho Saburi, MD, Keio University School of Medicine; Shinichiro Okamoto, MD, PhD, Keio University School of Medicine

299
Immunogenicity of a Lived-Attenuated Japanese Encephalitis Vaccine in Children after Hematopoietic Stem Cell Transplantation
Samart Pakakasama, Faculty of Medicine Ramathibodi Hospital, Mahidol University; Sumittra Wattanatitan, Faculty of Medicine Ramathibodi Hospital, Mahidol University; Chonnamet Techasaensiri, Faculty of Medicine Ramathibodi Hospital, Mahidol University; Sutee Yoksan, Center for Vaccine Development, Mahidol University; Somtawin Sirireung, Nursing services, Faculty of Medicine Ramathibodi Hospital, Mahidol University; Suradej Hongeng, Faculty of Medicine Ramathibodi Hospital, Mahidol University

300
A Multi-Disciplinary Approach to Identification and Treatment of Hyperglycemia on an Inpatient Hematopoietic Stem Cell Transplant (HSCT) Unit
Elizabeth Panter, RD, CNSC, CDE, Presbyterian/St. Luke's Medical Center; Joy Jordheim, RD, CNSC, CDE, Presbyterian/St. Luke's Medical Center; Lalani Dockter, MSN, CDE, Presbyterian/St. Lukes Medical Center; Sarah Bull, MD, Presbyterian/St. Luke's Medical Center; Leslie Gamache, MD, Presbyterian/St. Luke's Medical Center

302
The Role of Occupational Therapy and Its Impact on Quality of Life for the Pediatric Stem Cell Recipient
Alisha Nicole Pratt, OTR/L, Cincinnati Childrens Hospital Medical Center; Jill Marie Bakker, OTR/L MEd, Cincinnati Children's Hospital Medical Center

303
Determinants of Early and Late Transfusion Burden after Hematopoietic Stem Cell Transplantation (HSCT): An Analysis of 174 Transplant Recipients from a Single Center
Duncan Purtill, MBBS, FRACP, FRCPA, Royal Perth Hospital; Annette Le Viellez, Royal Perth Hospital; Julian P Cooney, MBBS FRACP FRCPA, Royal Perth Hospital Hem Dept; Richard Herrmann, MBBS FRACP FRCPA, Royal Perth Hospital; Matthew Wright, MBBS FRACP FRCPA, Royal Perth Hospital; Paul Cannell, MBBS FRCPA FRACP, Royal Perth Hospital

304
Effects of Calcineurin Inhibitors on Urinary Sodium Excretion Early after Allogenic Hematopoietic Stem Cell Transplantation
Masuho Saburi, MD, Keio University School of Medicine; Takehiko Mori, Keio University School of Medicine; Jun Kato, MD, Keio University School of Medicine; Yuya Koda, Keio University School of Medicine; Sumiko Kohashi, MD, Keio University School of Medicine; Shinichiro Okamoto, MD, PhD, Keio University School of Medicine

305
Antibiotic Prophylaxis Therapy for Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT): A Tale of 2 Centers
Tal Schechter, MD, The Hospital for Sick Children; Adam Gassas, MD, MBChB, MSc, MRCP, DCH, The Hospital for Sick Children; Joshua Klein, The Hospital for Sick Children; John Doyle, MD FRCPC FAAP, CancerCare Manitoba; Amanda Berger, PharmD, Vanderbilt University; Muhammad Ali, MD, The Hospital for Sick Children; Pengcheng Lu, M.S., Vanderbilt University; Jennifer Domm, MD, Vanderbilt University; Joerg Krueger, MD, The Hospital for Sick Children; R. Maarten Egeler, MD, PhD, The Hospital for Sick Children; Sarah Alexander, MD, The Hospital for Sick Children; Haydar A. Frangoul, MD, Vanderbilt University Medical Center

306
Improvement of Blood Glucose Control on the Bone Marrow Transplant (BMT) Unit: A Retrospective Review of Our Quality Improvement Pilot Program
Gunjan L. Shah, MD MS, Tufts Medical Center; Aaron Rosenberg, MD, Tufts Medical Center; Esha Kaul, MD, Tufts Medical Center; Ryan Stevenson, MD, Tufts Medical Center; Jaclyn Chin, RN BSN, Tufts Medical Center; Urvi Shah, MD, Tufts Medical Center; Amy Dinitz, MD, Tufts Medical Center; Furha Cossor, MD MS, Lahey Hospital & Medical Center; Hedy Smith, MD PhD, Tufts Medical Center; Andreas Klein, MD, Tufts Medical Center; Raymond Comenzo, MD, Tufts Medical Center; Kenneth B. Miller, MD, Tufts Medical Center; Richard A. Van Etten, MD PhD, University of California Irvine Medical Center; Richard Siegel, MD, Tufts Medical Center; Kellie A Sprague, MD, Tufts Medical Center

307
Retrospective Analysis of Oral Versus Intravenous Tacrolimus in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Katherine Simondsen, PharmD, University of Wisconsin Hospital and Clinics; Mary Mably, RPh, BCOP, University of Wisconsin Hospital and Clinics; Jessica Fischer, PharmD, BCOP, University of Wisconsin Hospital and Clinics; Linda Eckstein, RN, MSN, University of Wisconsin; Blythe Gage, University of Wisconsin Hospital and Clinics; Natalie Callander, MD, University of Wisconsin Hospital and Clinics

308
Palifermin Use in Lymphoma Patients Undergoing Autologous BEAM Transplants
Amir Steinberg, MD, Mount Sinai Hospital; Carroll Hayek, Mount Sinai Medical Center; Mary Toal, Mount Sinai Hospital; Eric Ursol, Mount Sinai Hospital; Zachary Galitzeck, Mount Sinai Hospital; Adriana K. Malone, MD, Mount Sinai Medical Center; Keren Osman, MD, Mount Sinai Medical Center; Eileen Scigliano, MD, Mount Sinai Hospital; Luis Isola, MD, Mount Sinai Medical Center

309
A Prospective, Randomized Clinical Trial of Cryotherapy Vs. Supersaturated Calcium Phosphate Rinses Vs. Saline Rinses for the Prevention of Oral Mucositis in Patients with Multiple Myeloma (MM) Receiving High-Dose Melphalan (HDM) and Autotransplantation
Juan J Toro, MD, MSCI, South Texas Veterans Health Care System; Deanna Schneider, BSN, South Texas Veterans Health Care System; Rosalinda Alonzo, RN, South Texas Veterans Health Care System; Abida Hasan, MS, South Texas Veterans Health Care System; Shuko Lee, MS, South Texas Veterans Health Care System; Francisca Gushiken, MD, South Texas Veterans Health Care System; David J Haile, MD, South Texas Veterans Health Care System; Cesar O. Freytes, MD, South Texas Veterans Health Care System

310
Amphotericin B Nasal Spray Appears Effective in Preventing Breakthrough Fungal Infections in Colonized SCT Recipients
Steven Trifilio, Northwestern Memorial Hospital; Ryan Heraty, Northwestern Memorial Hospital; Athanasios Zomas, Northwestern Memorial Hospital; Derek Liu, Northwestern Memorial Hospital; Junyu Zhang, Northwestern Memorial Hospital; Cindy Zhao, Northwestern Memorial Hospital; Jayesh Mehta, MD, Northwestern University Feinberg School of Medicine

311
Incidence and Outcomes of Bacteremia with Common Over-the-Counter Probiotic Organisms Among Hematopoietic Cell Transplant Recipients
Maresa Woodfield, Fred Hutchinson Cancer Research Center; Nicole Boyle, BA, Fred Hutchinson Cancer Research Center; Zach Stednick, MPH, Fred Hutchinson Cancer Research Center; Michael J. Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center; Steven A. Pergam, MD, MPH, Fred Hutchinson Cancer Research Center

312
Parametric Response Mapping as a Diagnostic Indicator of Bronchiolitis Obliterans Syndrome
Craig J Galban, PhD, University of Michigan; Jennifer L Boes, PhD, University of Michigan; Maria Bule, University of Michigan; Charles R Meyer, PhD, University of Michigan; Daniel R. Couriel, MD, University of Michigan; Carrie L. Kitko, MD, University of Michigan; Michael Ponkowski, University of Michigan; Timothy D Johnson, PhD, University of Michigan; Vibha Lama, MD, University of Michigan; Ella A Kazerooni, MD, University of Michigan; Brian D Ross, PhD, University of Michigan; Gregory Yanik, MD, University of Michigan

See more of: Poster Abstracts